Equity Capital Markets

Company · CIK 1974640

Apogee Therapeutics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1974640 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2023-08-28

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-281503
ShelfEffective
 2024-08-122026-03-255
333-277664
Registered companyFinal prospectus
 2024-03-052024-03-113
333-272831
IPOFinal prospectus
 2023-06-222023-07-175

Filings

15
FiledFilingRegistrationAccession
2026-03-25424B5Shelf takedown 333-2815030001104659-26-034562
2026-03-23424B5Shelf takedown 333-2815030001104659-26-033346
2025-10-10424B5Shelf takedown 333-2815030001104659-25-098480
2025-10-08424B5Shelf takedown 333-2815030001104659-25-097972
2024-08-12S-3ASRShelf registered 333-2815030001104659-24-088446
2024-03-11424B4Final prospectus 333-2776640001104659-24-032615
2024-03-07EFFECTDeclared effective 333-2776649999999995-24-000617
2024-03-05S-1Registration filed 333-2776640001104659-24-030994
2024-02-09DRSDraft made public 377-070930001104659-24-012964
2023-07-17424B4Final prospectus 333-2728310001104659-23-081627
2023-07-13EFFECTDeclared effective 333-2728319999999995-23-002082
2023-07-10S-1/AAmendment 333-2728310001104659-23-079247
2023-07-03S-1/AAmendment 333-2728310001104659-23-077648
2023-06-22S-1Registration filed 333-2728310001104659-23-073769
2023-04-28DRSDraft made public 377-066910001104659-23-052736

All filings of this company · CSV